Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Computerized decision making information system to direct the orders for patients sustaining multiple rib fractures. More
Novel agents that can interfere with the action of nuclear hormone receptors More
Method and Apparatus for Diagnosing Osteoporosis with MRI Imaging More
Clinical Applications of Serum HtrA1 as Markers for Pre-Eclampsia, Osteoarthritis and Cardiovascular Diseases More
Identification of NTproCNP: A Novel Biomarker to Predict Abnormal Growth More
Methods for Diagnosing and Treating Disease Associated with CMG-2 Deficiency More
Early Differential Diagnosis of Arthritis by Quantification of Hdj2 (DNAJA1) in Synovial Fluid More
A Robust Reporter System to Identify Bone Morphogentic (BMP) Activity More
Methods and Kits for the Diagnosis of Rheumatoid Arthritis More
Treatment and Diagnosis of Cell Proliferative Disorders: Elucidation of Transcription Factors Regulating FGF-2 More
Related Reports
Market Research Reports provided by reports.iptechex.com
Sep 2010 - 25 pages - $99
Apr 2011 - 250 pages - $2,695
Nov 2010 - 40 pages - $500
Aug 2010 - 27 pages - $125
Dec 2010 - 18 pages - $125
Feb 2011 - 17 pages - $125
May 2011 - 20 pages - $125
Jul 2010 - 26 pages - $99
Apr 2007 - 613 pages - $420
Dec 2010 - 25 pages - $500
Your selection
Browse By
- Therapeutic target
- Age-related disorders (other)
- Back pain
- Birth defects
- Bone cancer
- Chronic granulomatous disease
- Dupuytren's disease
- Dyskinesia
- Fibrocystic breast disease
- Gout
- Growth disorders
- Hypomobility
- Intermittent claudication
- Leprosy
- Lupus erythematosis
- Muscular
- Musculoskeletal disorder (other)
- Scleroderma
- Sjogren's syndrome
- Skeletal
- Trauma, physical
- Wasting disease
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us